A complete application in a minute
Tailored resume and cover letter, ready to send.
GlaxoSmithKline plc is seeking a Medical Science Liaison specialising in Oncology/Haematology to cover Ireland. You will act as a scientific partner to healthcare professionals, build evidence-based relationships, and bring insights back to internal teams.
As a field-based expert you will generate insights, support evidence-generation activities, and collaborate with Medical Affairs and Clinical Development to advance patient care. Closing date: 19 November 2026.
We are looking for a Medical Science Liaison specialising in Oncology/Haematology to join our team.
As the successful candidate you will act as a trusted scientific partner to healthcare professionals across Ireland focusing on Oncology/Haematology. You will build strong, evidence-based relationships and bring insights back to internal teams.
To be successful in this role you need to be passionate about scientific exchange, collaboration and advancing patient care. Whether your experience comes from Medical Affairs, clinical research, academia or industry, we welcome individuals who bring scientific expertise, curiosity and a commitment to making a meaningful impact.
As a field-based scientific expert you will build trusted partnerships with healthcare professionals, generate insights that shape medical strategy and support evidence-generation activities that advance patient outcomes.
We create a place where people can grow, be their best, be safe, and feel welcome, valued and included.
This is a field-based role supporting healthcare professionals and key stakeholders across Ireland.
Closing Date for Applications - 19th November 2026 (COB)
At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people's lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients' needs and have the highest probability of success. We're uniting science, technology, and talent to get ahead of disease together.